Cavadini E - Search Results

1

Involvement of AF1q/MLLT11 in the progression of ovarian cancer.

Tiberio P, Lozneanu L, Angeloni V, Cavadini E, Pinciroli P, Callari M, Carcangiu ML, Lorusso D, Raspagliesi F, Pala V, Daidone MG, Appierto V. Tiberio P, et al. Among authors: cavadini e. Oncotarget. 2017 Apr 4;8(14):23246-23264. doi: 10.18632/oncotarget.15574. Oncotarget. 2017. PMID: 28423573 Free PMC article.

2

Role of retinoic acid receptor overexpression in sensitivity to fenretinide and tumorigenicity of human ovarian carcinoma cells.

Pergolizzi R, Appierto V, Crosti M, Cavadini E, Cleris L, Guffanti A, Formelli F. Pergolizzi R, et al. Among authors: cavadini e. Int J Cancer. 1999 May 31;81(5):829-34. doi: 10.1002/(sici)1097-0215(19990531)81:5<829::aid-ijc26>3.0.co;2-3. Int J Cancer. 1999. PMID: 10328240 Free article.

3

Decrease in drug accumulation and in tumour aggressiveness marker expression in a fenretinide-induced resistant ovarian tumour cell line.

Appierto V, Cavadini E, Pergolizzi R, Cleris L, Lotan R, Canevari S, Formelli F. Appierto V, et al. Among authors: cavadini e. Br J Cancer. 2001 Jun 1;84(11):1528-34. doi: 10.1054/bjoc.2001.1826. Br J Cancer. 2001. PMID: 11384104 Free PMC article.

4

Altered sphingolipid metabolism in N-(4-hydroxyphenyl)-retinamide-resistant A2780 human ovarian carcinoma cells.

Prinetti A, Basso L, Appierto V, Villani MG, Valsecchi M, Loberto N, Prioni S, Chigorno V, Cavadini E, Formelli F, Sonnino S. Prinetti A, et al. Among authors: cavadini e. J Biol Chem. 2003 Feb 21;278(8):5574-83. doi: 10.1074/jbc.M207269200. Epub 2002 Dec 16. J Biol Chem. 2003. PMID: 12486134 Free article.

5

Fenretinide breast cancer prevention trial: drug and retinol plasma levels in relation to age and disease outcome.

Formelli F, Camerini T, Cavadini E, Appierto V, Villani MG, Costa A, De Palo G, Di Mauro MG, Veronesi U. Formelli F, et al. Among authors: cavadini e. Cancer Epidemiol Biomarkers Prev. 2003 Jan;12(1):34-41. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 12540501 Clinical Trial.

6

Involvement of c-Fos in fenretinide-induced apoptosis in human ovarian carcinoma cells.

Appierto V, Villani MG, Cavadini E, Lotan R, Vinson C, Formelli F. Appierto V, et al. Among authors: cavadini e. Cell Death Differ. 2004 Mar;11(3):270-9. doi: 10.1038/sj.cdd.4401349. Cell Death Differ. 2004. PMID: 14647238

7

Identification of the fenretinide metabolite 4-oxo-fenretinide present in human plasma and formed in human ovarian carcinoma cells through induction of cytochrome P450 26A1.

Villani MG, Appierto V, Cavadini E, Valsecchi M, Sonnino S, Curley RW, Formelli F. Villani MG, et al. Among authors: cavadini e. Clin Cancer Res. 2004 Sep 15;10(18 Pt 1):6265-75. doi: 10.1158/1078-0432.CCR-04-0655. Clin Cancer Res. 2004. PMID: 15448016 Clinical Trial.

8

4-oxo-fenretinide, a recently identified fenretinide metabolite, induces marked G2-M cell cycle arrest and apoptosis in fenretinide-sensitive and fenretinide-resistant cell lines.

Villani MG, Appierto V, Cavadini E, Bettiga A, Prinetti A, Clagett-Dame M, Curley RW, Formelli F. Villani MG, et al. Among authors: cavadini e. Cancer Res. 2006 Mar 15;66(6):3238-47. doi: 10.1158/0008-5472.CAN-05-3362. Cancer Res. 2006. PMID: 16540676

9

Analysis of gene expression identifies PLAB as a mediator of the apoptotic activity of fenretinide in human ovarian cancer cells.

Appierto V, Villani MG, Cavadini E, Gariboldi M, De Cecco L, Pierotti MA, Lambert JR, Reid J, Tiberio P, Colombo N, Formelli F. Appierto V, et al. Among authors: cavadini e. Oncogene. 2007 Jun 7;26(27):3952-62. doi: 10.1038/sj.onc.1210171. Epub 2007 Jan 8. Oncogene. 2007. PMID: 17213814

10

Pharmacokinetics of oral fenretinide in neuroblastoma patients: indications for optimal dose and dosing schedule also with respect to the active metabolite 4-oxo-fenretinide.

Formelli F, Cavadini E, Luksch R, Garaventa A, Villani MG, Appierto V, Persiani S. Formelli F, et al. Among authors: cavadini e. Cancer Chemother Pharmacol. 2008 Sep;62(4):655-65. doi: 10.1007/s00280-007-0649-7. Epub 2007 Dec 8. Cancer Chemother Pharmacol. 2008. PMID: 18066548 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

31 results

Search Page